Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?

Sheila Bermejo; Monica Bolufer; Mar Riveiro-Barciela; Maria Jose Soler

doi:10.3389/fmed.2022.906565

Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?

Sheila Bermejo, Monica Bolufer, Mar Riveiro-Barciela, Maria Jose Soler

Departament de Medicina

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

12 Cites (Scopus)

Idioma original	Anglès
Número d’article	906565
Pàgines (de-a)	1-9
Nombre de pàgines	9
Revista	Frontiers in Medicine
Volum	9
DOIs	https://doi.org/10.3389/fmed.2022.906565
Estat de la publicació	Publicada - 14 de juny 2022

Accés al document

10.3389/fmed.2022.906565

https://ddd.uab.cat/record/292934

Altres arxius i enllaços

https://www.scopus.com/pages/publications/85133505964

Com citar-ho

@article{f18fb1f73f224ae5bb92eb66d4187b63,

title = "Immunotherapy and the Spectrum of Kidney Disease: Should We Individualize the Treatment?",

keywords = "dialysis, chronic kidney disease, renal transplant, immunotherapy, renal biopsy",

author = "Sheila Bermejo and Monica Bolufer and Mar Riveiro-Barciela and Soler, \{Maria Jose\}",

year = "2022",

month = jun,

day = "14",

doi = "10.3389/fmed.2022.906565",

language = "English",

volume = "9",

pages = "1--9",

journal = "Frontiers in Medicine",